NCT00401531View on ClinicalTrials.gov

Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

August 31, 2008

Conditions
Hepatitis BPolioDiphtheriaPertussisHaemophilus Influenzae Type b
Interventions
BIOLOGICAL

DTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines

0.5 mL, IM

BIOLOGICAL

DTaP-HB-IPV and Pneumococcal polysaccharide vaccines

0.5 mL, IM

Trial Locations (2)

Unknown

Bangkok

Khonkaen

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00401531 - Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants | Biotech Hunter | Biotech Hunter